International Partner Search

Innovation & Technology Offer

UK company is offering their hot extrusion facilities to pharmaceutical companies developing new dosage forms

Country of Origin: United Kingdom
Reference Number: TOUK20201022001
Publication Date: 26 October 2020

Summary

UK company is offering their hot extrusion facilities to partners looking to develop API (active pharmaceutical ingredient) from early phase clinical development to large scale commercial production. They are the first GMP (Good Manufacturing Practices) company in the UK with hot extrusion facilities, and can also help partners with their contract research & manufacturing requirement in pharmaceutical new dosage, via manufacturing agreement.

Description

The UK company is a manufacturing and testing organisation, outfitted with a well-equipped tablet development lab and a  complete hot-melt extrusion line. 

The company provides advanced insights into drug development and formulation through advanced API (Active Pharmaceutical Ingredient) screening, economical manufacturing process and thorough physiochemical characterisation in order to develop safe and effective dosage forms.

They are looking for pharmaceutical companies to take advantage of their unique manufacturing capacity, to use in the  product development of children dosage forms of orally disintegrating tablets (ODTs), improving solubility, bio-availability, absorption of drug, stability improvement, drug manufacturing using co-crystal technology to improve solubility, bioavailability, absorption and stability

Advantages and Innovations

The UK company is the first GMP facility in the UK with hot melt extrusion. 

They employ renowned experts in tableting and extrusion technologies to ensure the products are produced in the most efficient, cost-effective, safes and environmentally-friendly manner possible. The company has a number of computational and experimental techniques to allow for thorough drug screening at its disposal, as well as a pedigree in identifying suitable multi-component systems, to suit their customer’s needs.

The company is equipped with a range of physical, chemical, dissolution, stability and microbiological testing equipment to allow them to discover every necessary detail about a

molecule to suit formulation, development and validation needs.

Stage Of Development

Already on the market

Requested partner

The UK company is offering manufacturing agreement to companies interested in doing product development of children dosage forms of orally disintegrating tablets (ODTs), improving solubility, bio-availability, absorption of drug, stability improvement, drug manufacturing using co-crystal technology to improve solubility, bioavailability, absorption and stability.

The UK company outsources contract research & manufacturing requirement in pharmaceutical new dosage forms.